Caribou Biosciences (CRBU) Tax Rate (2020 - 2021)
Caribou Biosciences (CRBU) posted quarterly Tax Rate of 1.77% for Q4 2021, down 412.0% year-over-year from 0.57% in Q4 2020, and down 175.19% quarter-over-quarter from 2.35% in Q4 2020.
Caribou Biosciences (CRBU) Tax Rate (2020 - 2021) Analysis & Trends
Caribou Biosciences (CRBU) has reported Tax Rate for 2 consecutive years, with 1.77% the latest figure, recorded in Q4 2021.
- In Q4 2021, Tax Rate fell 412.0% year-over-year to 1.77%; the TTM figure through Dec 2021 stood at 0.48% (down 552.0% YoY), while the FY2025 annual figure was 0.37%, up 36.0% from the prior year.
- Tax Rate fell to 1.77% in Q4 2021 per CRBU's latest filing, from 2.35% in the prior quarter.
- Across five years, Tax Rate topped out at 10.93% in Q1 2020 and bottomed at 1.77% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Caribou Biosciences | 166.63 Mn | 54.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.77% |
| Dec 31, 2021 | -1.77% |
| Dec 31, 2021 | -1.77% |
| Dec 31, 2020 | 2.35% |
| Dec 31, 2020 | 2.35% |
| Dec 31, 2020 | 2.35% |
| Sep 30, 2020 | 2.61% |
| Sep 30, 2020 | 2.61% |
| Sep 30, 2020 | 2.61% |
| Jun 30, 2020 | 2.60% |
| Jun 30, 2020 | 2.60% |
| Jun 30, 2020 | 2.60% |
| Mar 31, 2020 | 10.93% |
| Mar 31, 2020 | 10.93% |
| Mar 31, 2020 | 10.93% |